Globally, depression affects over 300 million people annually. Nearly 800,000 die from suicide every year - it is the second-leading cause of death among people between the ages of 15 to 29, researchers said.
The study, published in the Journal of Neuroscience, is the first to illuminate in detail how the gene, known as Slc6a15, works in a kind of neuron that plays a key role in depression. It found the link in both animals and humans.
"It suggests that people with altered levels of this gene in certain brain regions may have a much higher risk for depression and other emotional disorders related to stress," said Lobo.
Lobo and her team focused on a part of the brain called the nucleus accumbens which plays a central role in the brain's "reward circuit."
When you eat a delicious meal, have sex, drink alcohol, or have any other kind of enjoyable experience, neurons in the nucleus accumbens are activated, letting you know that the experience is pushing the proper buttons, researchers said.
The researchers focused on a subset of neurons in the nucleus accumbens called D2 neurons. These neurons respond to the neurotransmitter dopamine, which plays a central role in the reward circuit.
They studied mice susceptible to depression; when subjected to social stress - exposure to larger, more aggressive mice - they tend to withdraw and exhibit behaviour that indicates depression, such as social withdrawal and lack of interest in food that they normally enjoy.
Lobo found that when these animals were subjected to chronic social stress, levels of the Slc6a15 gene in the D2 neurons of the nucleus accumbens was markedly reduced.
Conversely, when the researchers enhanced Slc6a15 levels in D2 neurons, the mice showed a resilient response to stress.
Next, Lobo looked at the brains of humans who had a history of major depression and who had committed suicide. In the nucleus accumbens of these brains, the gene was reduced.
This indicates that the link between gene and behaviour extends from mice to humans, researchers said.
It is not clear exactly how Slc6a15 works in the brain. Lobo said it may work by altering neurotransmitter levels in the brain, a theory that has some evidence from other studies.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
